Filing Flows › ClearPoint Neuro (CLPT) › Guidance history
ClearPoint Neuro (CLPT) guidance history: what it guided and what it reported
ClearPoint Neuro gave guidance in 3 earnings releases on file since May 13, 2026. Its releases raised guidance 0 times and lowered it once.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $52.0M–$56.0M (May 13, 2026) → lowered $48.0M–$52.0M (Aug 3, 2026) → lowered $48.0M–$50.0M (Oct 28, 2026) | — | to be reported | — |
The latest quarter
ClearPoint Neuro, Q3 2026: revenue $12.1M (+36% year over year), operating margin -52.4%, net loss $7.5M, operating cash flow −$5.1M. The chart follows the revenue to costs, profit and cash.
Questions
Does ClearPoint Neuro beat its guidance?
ClearPoint Neuro gave guidance in 3 earnings releases on file since May 13, 2026. Its releases raised guidance 0 times and lowered it once.
How often does ClearPoint Neuro raise guidance?
Its earnings releases raised guidance 0 times and lowered it once since May 13, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.